Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas acquired 29,158 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $0.86 per share, with a total value of $25,075.88. Following the transaction, the chief executive officer now directly owns 4,164,789 shares of the company’s stock, valued at approximately $3,581,718.54. This represents a 0.71 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Grigorios Siokas also recently made the following trade(s):
- On Wednesday, January 15th, Grigorios Siokas acquired 62,500 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.80 per share, with a total value of $50,000.00.
- On Monday, January 13th, Grigorios Siokas acquired 163,666 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.61 per share, with a total value of $99,836.26.
- On Friday, December 20th, Grigorios Siokas bought 257,334 shares of Cosmos Health stock. The stock was purchased at an average price of $0.58 per share, with a total value of $149,253.72.
Cosmos Health Stock Up 3.8 %
NASDAQ COSM traded up $0.03 during trading hours on Tuesday, reaching $0.89. 177,450 shares of the company traded hands, compared to its average volume of 437,019. The stock has a market capitalization of $20.70 million, a PE ratio of -0.36 and a beta of 5.57. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08. Cosmos Health Inc. has a 12 month low of $0.47 and a 12 month high of $1.58. The company has a 50 day moving average of $0.72 and a two-hundred day moving average of $0.91.
Cosmos Health Company Profile
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Recommended Stories
- Five stocks we like better than Cosmos Health
- What Are Treasury Bonds?
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Gold’s Momentum Persists: Leading ETF and 2 Stocks to Watch
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.